Report
MarketLine Department
EUR 300.83 For Business Accounts Only

Generics in North America

Summary

Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The North American generics market had total revenues of $82.2 billion in 2022, representing a compound annual growth rate (CAGR) of 2.3% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 0.7% between 2017 and 2022, to reach a total of 85.3% in 2022.
- Factors such as accelerating healthcare costs and increasing abbreviated new drug application (ANDA) approvals are driving the generics market. According to the Food & Drug Administration’s (FDA) Office of Generic Drugs (OGD) 2022 Annual Report, in 2022, the generic drug program issued or tentatively authorized 914 ANDAs for generic drugs.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in North America
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America generics market with five year forecasts by both value and volume

Reasons To Buy

- What was the size of the North America generics market by value in 2022?
- What will be the size of the North America generics market in 2027?
- What factors are affecting the strength of competition in the North America generics market?
- How has the market performed over the last five years?
- Who are the top competitors in North America's generics market?
Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch